BlackRock Institutional Trust’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $15.4M | Buy |
459,134
+68,446
| +18% | +$2.29M | ﹤0.01% | 2149 |
|
|
2016
Q3 | $10.4M | Buy |
390,688
+14,440
| +4% | +$384K | ﹤0.01% | 2309 |
|
|
2016
Q2 | $8.3M | Buy |
376,248
+2,052
| +0.5% | +$45.2K | ﹤0.01% | 2399 |
|
|
2016
Q1 | $11M | Sell |
374,196
-120
| -0% | -$3.52K | ﹤0.01% | 2197 |
|
|
2015
Q4 | $12.4M | Sell |
374,316
-21,267
| -5% | -$702K | ﹤0.01% | 2191 |
|
|
2015
Q3 | $14.3M | Buy |
395,583
+40,692
| +11% | +$1.47M | ﹤0.01% | 2068 |
|
|
2015
Q2 | $16M | Buy |
354,891
+30,246
| +9% | +$1.36M | ﹤0.01% | 2077 |
|
|
2015
Q1 | $9.94M | Buy |
324,645
+155,786
| +92% | +$4.77M | ﹤0.01% | 2392 |
|
|
2014
Q4 | $8.59M | Buy |
168,859
+16,309
| +11% | +$829K | ﹤0.01% | 2448 |
|
|
2014
Q3 | $6.04M | Buy |
152,550
+36,386
| +31% | +$1.44M | ﹤0.01% | 2601 |
|
|
2014
Q2 | $5M | Buy |
116,164
+75,915
| +189% | +$3.27M | ﹤0.01% | 2789 |
|
|
2014
Q1 | $1.61M | Sell |
40,249
-12,742
| -24% | -$510K | ﹤0.01% | 3251 |
|
|
2013
Q4 | $1.45M | Sell |
52,991
-28,935
| -35% | -$790K | ﹤0.01% | 3273 |
|
|
2013
Q3 | $1.88M | Sell |
81,926
-101,707
| -55% | -$2.33M | ﹤0.01% | 3155 |
|
|
2013
Q2 | $3.25M | Buy |
+183,633
| New | +$3.25M | ﹤0.01% | 2882 |
|